Columbia Trust’s Pfizer PFE Stock Holding History

Columbia Trust’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	$204K	Sell	7,074 -875	-11%	-$26.5K	0.09%	143
2023 Q3	$264K	Buy	7,949 +156	+2%	+$5.52K	0.15%	113
2023 Q2	$286K	Sell	7,793 -308	-4%	-$12K	0.16%	109
2023 Q1	$331K	Sell	8,101 -1,761	-18%	-$76.1K	0.19%	112
2022 Q4	$505K	Sell	9,862 -858	-8%	-$41.1K	0.28%	90
2022 Q3	$469K	Buy	10,720 +875	+9%	+$42.5K	0.26%	89
2022 Q2	$516K	Hold	9,845	–	–	0.28%	86
2022 Q1	$523K	Buy	9,845 +1,825	+23%	+$94.7K	0.24%	94
2021 Q4	$345K	Hold	8,020	–	–	0.18%	110
2021 Q3	$345K	Buy	8,020 +365	+5%	+$16.2K	0.18%	110
2021 Q2	$300K	Sell	7,655 -1,197	-14%	-$46.5K	0.17%	114
2021 Q1	$320K	Sell	8,852 -1,741	-16%	-$61.8K	0.2%	117
2020 Q4	$389K	Buy	+10,593	New	+$389K	0.27%	97
2020 Q2	$308K	Sell	9,941 -870	-8%	-$29.6K	0.27%	96
2020 Q1	$334K	Buy	10,811 +635	+6%	+$21.6K	0.37%	80
2019 Q4	$377K	Buy	+10,176	New	+$362K	0.34%	90

Other funds holding PFE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Columbia Trust's PFE Position: Q4 2023 in Review

Columbia Trust reduced its Pfizer (PFE) stake by 11% in Q4 2023, selling an estimated $26.5K and leaving 7,074 shares worth $204K. The position accounts for 0.09% of the portfolio, ranked #143.

Columbia Trust first reported a position in PFE in Q4 2019 and has held it in 16 quarters since. The position peaked at $523K in Q1 2022. 2,935 funds tracked by Wall St. Rank hold PFE as of Q4 2023.

Columbia Trust held 7,074 shares of Pfizer worth $204K as of Q4 2023.
Columbia Trust sold 875 Pfizer shares in Q4 2023, an estimated $26.5K.
Pfizer made up 0.09% of Columbia Trust's portfolio in Q4 2023, its #143 holding.
Columbia Trust first reported a position in Pfizer in Q4 2019 and has held it in 16 quarters since.
Columbia Trust's Pfizer position peaked at $523K in Q1 2022.
2,935 funds tracked by Wall St. Rank held Pfizer as of Q4 2023.

Based on Columbia Trust's 13F filing for Q4 2023, filed 17 Jan 2024.